Acerta Pharma B.V.

Organization

Oss, NL

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Processes for the preparation of 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)...
- Patent number 12,024,520
- Issue date Jul 2, 2024
- Acerta Pharma B.V.
- Paul Allen Bethel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)i...
- Patent number 11,820,777
- Issue date Nov 21, 2023
- Acerta Pharma B.V.
- Fritz Blatter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating chronic lymphocytic leukemia and small lymphocy...
- Patent number 11,771,696
- Issue date Oct 3, 2023
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JA...
- Patent number 11,654,143
- Issue date May 23, 2023
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for use of therapeutic T cells in combinat...
- Patent number 11,590,167
- Issue date Feb 28, 2023
- Juno Therapeutic, Inc.
- Michael Ports
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JA...
- Patent number 11,166,951
- Issue date Nov 9, 2021
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazopyrazine inhibitors of Bruton's tyrosine kinase
- Patent number 11,110,088
- Issue date Sep 7, 2021
- Acerta Pharma B.V.
- Tjeerd Barf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating chronic lymphocytic leukemia and small lymphocy...
- Patent number 11,090,302
- Issue date Aug 17, 2021
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)i...
- Patent number 11,059,829
- Issue date Jul 13, 2021
- Acerta Pharma B.V.
- Fritz Blatter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazopyrazine inhibitors of Bruton's tyrosine kinase
- Patent number 10,858,364
- Issue date Dec 8, 2020
- Acerta Pharma B.V.
- Terry Podoll
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyrazine inhibitors of Bruton's tyrosine kinase
- Patent number 10,736,893
- Issue date Aug 11, 2020
- Acerta Pharma B.V.
- Tjeerd Barf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical composition comprising a crystal form of (S)-4-(8-am...
- Patent number 10,640,509
- Issue date May 5, 2020
- Acerta Pharma B.V.
- Fritz Blatter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic combination of PI3K inhibitor and a BTK inhibitor
- Patent number 10,328,080
- Issue date Jun 25, 2019
- Acerta Pharma, B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating chronic lymphocytic leukemia and small lymphocy...
- Patent number 10,272,083
- Issue date Apr 30, 2019
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition comprising a crystal form of (S)-4-(8-am...
- Patent number 10,167,291
- Issue date Jan 1, 2019
- Acerta Pharma B.V.
- Fritz Blatter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/o...
- Patent number 9,949,971
- Issue date Apr 24, 2018
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of blocking the CXCR-4/SDF-1 signaling pathway with inhibit...
- Patent number 9,937,171
- Issue date Apr 10, 2018
- Acerta Pharma B.V.
- Raquel Izumi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)i...
- Patent number 9,796,721
- Issue date Oct 24, 2017
- Acerta Pharma B.V.
- Fritz Blatter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bruton's tyrosine kinase inhibitors for hematopoietic mobilization
- Patent number 9,522,917
- Issue date Dec 20, 2016
- Acerta Pharma B.V.
- Raquel Izumi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
1-H-PYRROLO[2,3-c]PYRIDINE COMPOUNDS
- Publication number 20240335431
- Publication date Oct 10, 2024
- Acerta Pharma B.V.
- Stephen ATKINSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR THE PREPARATION OF 4-{8-AMINO-3-[(2S)-1-(BUT-2-YNOYL)...
- Publication number 20240317766
- Publication date Sep 26, 2024
- Acerta Pharma B.V.
- Paul Allen BETHEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumo...
- Publication number 20240216380
- Publication date Jul 4, 2024
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)...
- Publication number 20240199622
- Publication date Jun 20, 2024
- Acerta Pharma B.V.
- Fritz Blatter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Combinations of a CD19 Inhibitor and a BTK Inhibitor
- Publication number 20240197742
- Publication date Jun 20, 2024
- Acerta Pharma B.V.
- Wayne Rothbaum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocy...
- Publication number 20240180904
- Publication date Jun 6, 2024
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINAT...
- Publication number 20240016840
- Publication date Jan 18, 2024
- Juno Therapeutics, Inc.
- Michael Ports
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACALABRUTINIB MALEATE DOSAGE FORMS
- Publication number 20230226049
- Publication date Jul 20, 2023
- Acerta Pharma B.V.
- Paul BETHEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)...
- Publication number 20220348582
- Publication date Nov 3, 2022
- Acerta Pharma B.V.
- Fritz Blatter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)...
- Publication number 20220177476
- Publication date Jun 9, 2022
- Acerta Pharma B.V.
- Frtiz Blatter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR THE PREPARATION OF 4-{8-AMINO-3-[(2S)-1-(BUT-2-YNOYL)...
- Publication number 20220127270
- Publication date Apr 28, 2022
- Acerta Pharma B.V.
- Paul Allen BETHEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JA...
- Publication number 20220088013
- Publication date Mar 24, 2022
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocy...
- Publication number 20210401835
- Publication date Dec 30, 2021
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumo...
- Publication number 20210346382
- Publication date Nov 11, 2021
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Cancers, Immune and Autoimmune Diseases, and In...
- Publication number 20210322408
- Publication date Oct 21, 2021
- Acerta Pharma B.V.
- Brian Lannutti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Imidazopyrazine Inhibitors of Bruton's Tyrosine Kinase
- Publication number 20200330461
- Publication date Oct 22, 2020
- Acerta Pharma B.V.
- Tjeerd Barf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)...
- Publication number 20200255437
- Publication date Aug 13, 2020
- Acerta Pharma B.V.
- Fritz Blatter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JA...
- Publication number 20200069796
- Publication date Mar 5, 2020
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
- Publication number 20200069668
- Publication date Mar 5, 2020
- Acerta Pharma B.V.
- Brian Lannutti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumo...
- Publication number 20190381044
- Publication date Dec 19, 2019
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Combinations of an Antifolate and a BTK Inhibitor
- Publication number 20190374543
- Publication date Dec 12, 2019
- Acerta Pharma B.V.
- Allard Kaptein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor
- Publication number 20190374539
- Publication date Dec 12, 2019
- Acerta Pharma B.V.
- Wayne Rothbaum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Combination of a PI3K Inhibitor and a BTK Inhibitor
- Publication number 20190358235
- Publication date Nov 28, 2019
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Solid Forms and Formulations of Imidazopyrazine Compound
- Publication number 20190337949
- Publication date Nov 7, 2019
- Acerta Pharma B.V.
- Fritz Blatter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINAT...
- Publication number 20190328786
- Publication date Oct 31, 2019
- Juno Therapeutic, Inc.
- Michael PORTS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods of Treating Cancers, Immune and Autoimmune Diseases, and In...
- Publication number 20190314369
- Publication date Oct 17, 2019
- Acerta Pharma B.V.
- Brian Lannutti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocy...
- Publication number 20190290644
- Publication date Sep 26, 2019
- Acerta Pharma B.V.
- Ahmed Hamdy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Blocking the CXCR-4/SDF-1 Signaling Pathway With Inhibit...
- Publication number 20190231775
- Publication date Aug 1, 2019
- Acerta Pharma B.V.
- Raquel IZUMI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor
- Publication number 20190209591
- Publication date Jul 11, 2019
- Acerta Pharma B.V.
- Brian Lannutti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Combinations of a BTK Inhibitor and a GITR Binding Mole...
- Publication number 20190022092
- Publication date Jan 24, 2019
- Acerta Pharma B.V.
- Wayne Rothbaum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Acerta Pharma B.V.

Organization

Patents Grantslast 30 patents

Processes for the preparation of 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)...

Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)i...

Methods of treating chronic lymphocytic leukemia and small lymphocy...

Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JA...

Methods and compositions for use of therapeutic T cells in combinat...

Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JA...

Imidazopyrazine inhibitors of Bruton's tyrosine kinase

Methods of treating chronic lymphocytic leukemia and small lymphocy...

Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)i...

Imidazopyrazine inhibitors of Bruton's tyrosine kinase

Imidazopyrazine inhibitors of Bruton's tyrosine kinase

Pharmaceutical composition comprising a crystal form of (S)-4-(8-am...

Therapeutic combination of PI3K inhibitor and a BTK inhibitor

Methods of treating chronic lymphocytic leukemia and small lymphocy...

Pharmaceutical composition comprising a crystal form of (S)-4-(8-am...

Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/o...

Methods of blocking the CXCR-4/SDF-1 signaling pathway with inhibit...

Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)i...

Bruton's tyrosine kinase inhibitors for hematopoietic mobilization

Patents Applicationslast 30 patents

1-H-PYRROLO[2,3-c]PYRIDINE COMPOUNDS

PROCESSES FOR THE PREPARATION OF 4-{8-AMINO-3-[(2S)-1-(BUT-2-YNOYL)...

BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumo...

Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)...

Therapeutic Combinations of a CD19 Inhibitor and a BTK Inhibitor

Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocy...

METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINAT...

ACALABRUTINIB MALEATE DOSAGE FORMS

Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)...

Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)...

PROCESSES FOR THE PREPARATION OF 4-{8-AMINO-3-[(2S)-1-(BUT-2-YNOYL)...

Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JA...

Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocy...

BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumo...

Methods of Treating Cancers, Immune and Autoimmune Diseases, and In...

Imidazopyrazine Inhibitors of Bruton's Tyrosine Kinase

Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)...

Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JA...

Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor

BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumo...

Therapeutic Combinations of an Antifolate and a BTK Inhibitor

Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor

Therapeutic Combination of a PI3K Inhibitor and a BTK Inhibitor

Solid Forms and Formulations of Imidazopyrazine Compound

METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINAT...

Methods of Treating Cancers, Immune and Autoimmune Diseases, and In...

Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocy...

Methods of Blocking the CXCR-4/SDF-1 Signaling Pathway With Inhibit...

Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor

Therapeutic Combinations of a BTK Inhibitor and a GITR Binding Mole...

Trademarklast 30 trademarks